
Altria's growth stalls as smokable product sales decline, but dividends and cash flow keep it attractive with 12% upside.
Altria's Q2 and H1 results showed flat revenue growth and ongoing challenges in expanding into e-vapor and oral tobacco markets. Despite these setbacks, the company maintains strong cash flow and pricing power, supporting a fair value estimate of $76...


